The Global Neuralgia Treatment Market to grow from USD 691.67 Million in 2019 to USD 1,301.31 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 11.10%.
Market Segmentation & Coverage:
The research report categorizes the Neuralgia Treatment Market to forecast the revenues and analyze the trends in each of the following segments:
Based on Treatment Type, the Neuralgia Treatment Market studied across Drug Based and Surgery. The Drug Based further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery.
Based on Indication, the Neuralgia Treatment Market studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia.
Based on Distribution Channel, the Neuralgia Treatment Market studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
"The Asia-Pacific is projected to witness the highest growth during the forecast period"
Based on Geography, the Neuralgia Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neuralgia Treatment Market in 2019, followed by the Europe, Middle East & Africa. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.
The factors attributing to the growth of the market are government initiatives to spread awareness regarding neuralgia treatment products and increasing incidences of neuralgia due to the rise in the aging population. However, some factors such as high-cost associated with the treatment of neuralgia may hinder the market growth. The Neuralgia Treatment Market expected to showcase the opportunities such as developing surgical and pharmacological treatment in developing economies and technological advancement eliminates the need for drugs and surgery. Soon market may face the possible challenges in the growth due to persistent side effects from medications. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuralgia Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The Neuralgia Treatment Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuralgia Treatment Market, including Biogen Inc., Cadila Healthcare Limited, Cephalon Inc., GlaxoSmithKline PLC, GLENMARK PHARMS LTD., H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., LGM Pharma LLC, Lupin Limited, Novartis AG, Pfizer Inc., Psychotropics India Limited, Takeda Pharmaceutical Company Limited, Teikoku Pharma USA, Inc., Teva Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB Group.